These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 3037380)

  • 1. A factor discriminating between the wild-type and a mutant polyomavirus enhancer.
    Kovesdi I; Satake M; Furukawa K; Reichel R; Ito Y; Nevins JR
    Nature; 1987 Jul 2-8; 328(6125):87-9. PubMed ID: 3037380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Induction of a factor that binds to the polyoma virus A enhancer on differentiation of embryonal carcinoma cells.
    Kryszke MH; Piette J; Yaniv M
    Nature; 1987 Jul 16-22; 328(6127):254-6. PubMed ID: 3037385
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A mutated polyoma virus enhancer which is active in undifferentiated embryonal carcinoma cells is not repressed by adenovirus-2 E1A products.
    Hen R; Borrelli E; Fromental C; Sassone-Corsi P; Chambon P
    Nature; 1986 May 15-21; 321(6067):249-51. PubMed ID: 3012353
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polyomavirus enhancer requirements for expression in embryonal carcinoma cells.
    Couture LA; Lehman JM
    Int J Dev Biol; 1993 Mar; 37(1):125-33. PubMed ID: 8389574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional activity in 3T3, F9, and PCC4 embryonal carcinoma cells: a systematic deletion and linker-scanning study of the polyomavirus enhancer.
    Trotot P; Mechali F; Blangy D; Lacasa M
    Virology; 1994 Aug; 202(2):724-34. PubMed ID: 8030236
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activities of oligonucleotides spanning the F9 point mutation within the enhancer region of polyomavirus DNA.
    Satake M; Furukawa K; Ito Y
    J Virol; 1988 Mar; 62(3):970-7. PubMed ID: 2828692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A trans-acting factor represses the activity of the polyoma virus enhancer in undifferentiated embryonal carcinoma cells.
    Sassone-Corsi P; Fromental C; Chambon P
    Oncogene Res; 1987 Jul; 1(2):113-9. PubMed ID: 2835729
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of proteins binding to the F441 locus of polyomavirus B enhancer that are required for its activity in embryonic carcinoma cells.
    DasGupta S; Shivakumar CV; Das GC
    J Gen Virol; 1993 Apr; 74 ( Pt 4)():597-605. PubMed ID: 8385690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kilham polyomavirus: activation of gene expression and DNA replication in mouse fibroblast cells by an enhancer substitution.
    Zhang S; Magnusson G
    J Virol; 2001 Nov; 75(21):10015-23. PubMed ID: 11581370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transcriptional activity of human papillomavirus type 31b enhancer is regulated through synergistic interaction of AP1 with two novel cellular factors.
    Kyo S; Tam A; Laimins LA
    Virology; 1995 Aug; 211(1):184-97. PubMed ID: 7645210
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique requirement for the PyF441 mutation for polyomavirus infection of F9 embryonal carcinoma cells.
    Tseng RW; Williams T; Fujimura FK
    J Virol; 1988 Aug; 62(8):2896-902. PubMed ID: 2839708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A polyomavirus enhancer mutant confers ubiquitous high transcriptional efficiency to the SV40 late promoter.
    Fimia GM; Ferreira R; Passananti C; Amati P
    Biochem Biophys Res Commun; 1995 Feb; 207(1):339-47. PubMed ID: 7857287
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The EndoA enhancer contains multiple ETS binding site repeats and is regulated by ETS proteins.
    Seth A; Robinson L; Panayiotakis A; Thompson DM; Hodge DR; Zhang XK; Watson DK; Ozato K; Papas TS
    Oncogene; 1994 Feb; 9(2):469-77. PubMed ID: 7507230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Suboptimal enhancer sequences are required for efficient bovine leukemia virus propagation in vivo: implications for viral latency.
    Merezak C; Pierreux C; Adam E; Lemaigre F; Rousseau GG; Calomme C; Van Lint C; Christophe D; Kerkhofs P; Burny A; Kettmann R; Willems L
    J Virol; 2001 Aug; 75(15):6977-88. PubMed ID: 11435578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple domains in the polyomavirus B enhancer are required for productive infection of F9 embryonal carcinoma cells.
    Tseng RW; Fujimura FK
    J Virol; 1988 Aug; 62(8):2890-5. PubMed ID: 2839707
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Analysis of transcription factors binding to the duplicated PEA1 and PEA3 sites that are required for polyomavirus mutant expression in PCC4 embryonic carcinoma cells.
    Nothias JY; Weinmann R; Blangy D; Melin F
    J Virol; 1993 Jun; 67(6):3036-47. PubMed ID: 8388487
    [TBL] [Abstract][Full Text] [Related]  

  • 17. BOX DNA: a novel regulatory element related to embryonal carcinoma cell differentiation.
    Kihara-Negishi F; Tsujita R; Negishi Y; Ariga H
    Mol Cell Biol; 1993 Dec; 13(12):7747-56. PubMed ID: 7902532
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptional regulation of the hepatocyte growth factor (HGF) gene by the Sp family of transcription factors.
    Jiang JG; Chen Q; Bell A; Zarnegar R
    Oncogene; 1997 Jun; 14(25):3039-49. PubMed ID: 9223667
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A cell-type-specific transcription enhancer of type 16 human papillomavirus (HPV 16)-P97 promoter is defined with HPV-associated cellular events in human epithelial cell lines.
    Taniguchi A; Kikuchi K; Nagata K; Yasumoto S
    Virology; 1993 Aug; 195(2):500-10. PubMed ID: 8393236
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of viral enhancer "core" motif-related sequences in regulating T cell receptor-gamma and -delta gene expression.
    Hsiang YH; Spencer D; Wang S; Speck NA; Raulet DH
    J Immunol; 1993 May; 150(9):3905-16. PubMed ID: 8473739
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.